There comes a point in the life of every brand when exclusivity will be lost and generics will begin to compete for market share. However this is not the end of the brand’s lifecycle and many ...
StockStory.org on MSN3d
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals StocksAs the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche ...
Here's a good one that's getting some interesting responses: @thebennettbus on TikTok asked her followers, "What's the one thing you'll never buy generic?" ...
But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug manufacturers at a fraction of the cost. Here’s more about this ...
The Indian Pharmaceutical Alliance refutes a study claiming Indian generic drugs have higher adverse events, stating quality ...
A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results